Resilience: The Science of Mastering Life's Greatest Challenges

Tuesday, July 9, 2013
Resilience: The Science of Mastering Life's Greatest Challenges

Watch Video Recording:

Presented by 
Dennis S. Charney, M.D.
Dennis S. Charney, M.D.
Icahn School of Medicine at Mount Sinai

Dean

President for Academic Affairs

Scientific Council Member Emeritus

2019 Colvin Prizewinner for Outstanding Achievement in Mood Disorders Research

 

Dr. Dennis Charney is a world expert in the neurobiology and treatment of mood and anxiety disorders, having made fundamental contributions to the understanding of the causes of human anxiety, fear, and depression, and the discovery of new treatments for mood and anxiety disorders. His research on depression has led to discovery of novel therapies for treatment-resistant depression including ketamine and the first digital treatment for depression (the Emotional Faces Memory Task, or EFMT).

Dr. Charney has been honored with many of the major awards in his field for his scientific research, including World’s Most Influential Scientific Minds 2014 and 2015, and ranked 48 out of 1,360 of Most Highly Cited Life Science Researchers in the World. His discovery with his co-inventors of the use of intranasal ketamine for the treatment of treatment-resistant depression was named by Cleveland Clinic on its Top 10 list of 2017 Health Care Innovations. He holds three U.S. Patents, and 19 U.S. and Foreign Patent Applications, 10 of which are licensed to two companies.

He has published 785 articles and book chapters and 16 books, including Resilience: The Science of Mastering Life’s Greatest Challenges, and Charney & Nestler’s Neurobiology of Mental Illness, 5th Edition. Dr. Charney was elected to the National Academy of Medicine in 2000, and the National Academy of Inventors in 2017.

Moderated by
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation
 

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein served as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association from 2012 - 2023.

Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.